August 2022 "Chemokines, a subgroup of cytokines along with their receptors, are involved in various C-X-C motif chemokine receptor 4 (CXCR4), a G-protein-coupled receptor (GPCR), has one identified natural

discovery This Week’s GPCR Intelligence: Every drug you design will meet an enzyme before it meets its receptor Enzyme Inhibition Shapes Every Discovery Program Every molecule meets an enzyme before it ever meets its receptor Read the Feature ➤ Summer Days: Appetite, Suntans, and GPCR Micro-Domains Two recent papers connect ciliary signaling, opsins, and melanocortin receptors to behaviors and skin biology. Why micro-domains change what “global” signaling can and can’t explain.

steered molecular dynamics in uncovering the dissociation kinetics of ligands targeting G-protein-coupled receptors absolute residence times of the antagonist ZMA241385 and agonist NECA that target the A2A adenosine receptor of the G-protein-coupled receptor (GPCR) protein family. thermodynamics of ligand binding in terms of ligand binding energies and the per-residue contribution of the receptor

modulating its degradation (versus direct inhibition); selectivity frameworks for β₂ vs β₁ adrenergic receptors tp structural insights into cholesterol interactions in the active conformation of GLP‑1 receptor Terry's Eliminate fix/perm distortions:  Preserve receptor conformation and downstream signaling integrity.

GPCRs in Neuroscience Photopharmacological manipulation of amygdala metabotropic glutamate receptor mGlu4 in Oncology and Immunology Pan-cancer functional analysis of somatic mutations in G protein-coupled receptors Stability. iORbase: a database for the prediction of the structures and functions of insect olfactory receptors Sosei Heptares' Partner Pfizer Progresses its Oral GLP-1 Receptor Agonist PF-07081532 into Phase 2 Clinical Deadline February 12, 2023 Current Technologies To Understand G-Protein-Coupled Receptor Molecular Pharmacology

Discovery and In Vivo Evaluation of ACT-660602: A Potent and Selective Antagonist of the Chemokine Receptor CXCR3 for Autoimmune Diseases "The chemokine receptor CXCR3 is a seven-transmembrane G-protein-coupled receptor (GPCR) involved in various pathologies, in particular autoimmune diseases.

the paraventricular nucleus of the hypothalamus, where it interacts with various G protein-coupled receptors , such as the prokineticin receptors, and regulates energy expenditure and appetite. Understanding the mechanism by which MRAP2 regulates G protein-coupled receptors helps in elucidating

in living cells "β-arrestins mediate regulatory processes for over 800 different G protein-coupled receptors finger-loop-region, we show that the two isoforms prefer to associate with the active parathyroid hormone 1 receptor Here, we show differences between conformational changes that are induced by P-R* or R* receptor states

Lipids Are an Integral Part of Transmembrane Allosteric Sites in GPCRs: A Case Study of Cannabinoid CB1 Receptor Bound to a Negative Allosteric Modulator, ORG27569, and Analogs "A growing number of G-protein-coupled receptor in the access and binding of ORG27569 and its analogs at the transmembrane site of cannabinoid CB1 receptor

Kotliar sums it up best: “We went from one receptor to many… and now, from many, we can go back to one

October 2022 "While the role of G-protein-coupled receptors (GPCR) in cancer is acknowledged, their underlying Protease-activated receptors (PAR), a subgroup of GPCRs, form a family of four members (PAR1-4) centrally Point mutations are in the C-tail of PAR4 PH-binding domain; F347 L and D349A, but not E346A, abrogate AYPGKF peptide ligand activation of PAR4 induces EGF receptor (EGFR) Tyr-phosphorylation, effectively

Somatostatin receptors (SSTs) are class A GPCRs abundantly expressed in pituitary tumors where they represent The cytoskeletal protein filamin A (FLNA) directly interacts with both somatostatin receptor type 2 ( octreotide or pasireotide may play modulatory effects and whether FLNA may participate to this level of receptor On the contrary, in M2 cells, octreotide failed to internalize both receptors whereas pasireotide promoted robust receptor internalization at shorter times than in A7 cells.

Hébert and their colleagues research on 'G Protein-Biased Agonists for Intracellular Angiotensin Receptors GPCR Activation and Signaling G Protein-Biased Agonists for Intracellular Angiotensin Receptors Promote Myofibroblasts β-arrestin-dependent and -independent endosomal G protein activation by the vasopressin type 2 receptor with Nonobstructive Azoospermia GPCRs in Neuroscience Molecular insights into orphan G protein-coupled receptors Structural basis for the allosteric modulation of rhodopsin by nanobody binding to its extracellular domain

Cardiometabolic Disease: Recent Findings in Studies with Hormone Peptide-Derived G Protein Coupled Receptor glucose-dependent insulinotropic polypeptide (GIP) which exert their functions through G protein-coupled receptors Great success has been reached with therapies based on the GLP-1 receptor monoagonism; therefore, a logical

September 2022 "Receptor-activity-modifying proteins (RAMPs) are ubiquitously expressed membrane proteins that associate with different G protein–coupled receptors (GPCRs), including the parathyroid hormone 1 receptor (PTH1R), a class B GPCR and an important modulator of mineral ion homeostasis and bone metabolism

Abs against the angiotensin II receptor subtype 1 (AT1R) and the endothelin receptor type A (ETAR) are Promising nuclear receptors as key regulators of transcriptional programmes will be introduced as well

September 2022 "G protein-coupled receptor (GPCR) kinases (GRKs) and arrestins mediate GPCR desensitization evidence that distal carboxyl-terminal tail (C-tail), but not proximal, phosphorylation of the chemokine receptor We demonstrate by pharmacologic inhibition of GRK2/3-mediated phosphorylation of the chemokine receptor

Reading those first papers on GPCR signaling organization absolutely fascinated me — the idea that receptors to integrated signaling landscapes, accelerating drug discovery timelines and expanding targetable receptor

Her early work didn’t involve groundbreaking receptor models or million-dollar grants. within the Drug Discovery Biology theme at Monash Institute of Pharmaceutical Sciences, exploring how receptors

October 2022 "We describe production of the human A2A adenosine receptor (A2AAR), a class A G protein-coupled receptor (GPCR) for 19F-NMR and single-molecule fluorescence (SMF) spectroscopy.

2022 In vitro assays for the functional characterization of (psychedelic) substances at the serotonin receptor induce alterations in mood, perception, and thought, and have the activation of serotonin (5-HT) 2A receptors arachidonic acid release), assays to monitor β-arrestin recruitment or signaling, and assays to monitor receptor

September 2022 "G protein‐coupled receptors (GPCRs) are valuable therapeutic targets for many diseases We hypothesized that there is a common set of receptor interactions made by ligands of diverse structures β2AR structures, generating ca 75 000 docking poses and predicted all atomic interactions between the receptor

August 2022 "Three classes of G-protein-coupled receptor (GPCR) partners - G proteins, GPCR kinases, differences in the orientation of individual residues and/or their interactions not easily detectable in the receptor-transducer

cAMP assay: Temperature optimization and application to cell-based kinetic studies "G protein-coupled receptors (GPCRs) are an important receptor superfamily and common therapeutic targets. optimization studies were carried out using HEK293H cells transiently transfected with the adenosine receptor

F-NMR and single-molecule fluorescence spectroscopy "We describe production of the human A2A adenosine receptor (A2AAR), a class A G protein-coupled receptor (GPCR) for 19F-NMR and single-molecule fluorescence (SMF

GPCRs in Oncology and Immunology Ovarian cancer G protein-coupled receptor 1 (OGR1) deficiency exacerbates β2AR Using Native Mass Spectrometry. psnGPCRdb: The Structure-network Database of G Protein Coupled Receptors Reviews, GPCRs, and more Optical approaches for investigating neuromodulation and G Protein-Coupled Receptor

By targeting the receptors synaptically or non-synaptically, neurotransmitters activate multiple signaling Significantly, many ligands acting on neurotransmitter receptors have shown great potential for inhibiting

Methods: To address this question, we studied mice that express a Gs-coupled designer G protein-coupled receptor two Gs-coupled GPCRs that are endogenously expressed by SKM at relatively high levels (β2-adrenergic receptor and CRF2 receptor) and studied the acute metabolic effects of activating these receptors in vivo by The acute metabolic effects following agonist activation of β2-adrenergic and, potentially, CRF2 receptors impact on whole-body glucose homeostasis, most likely due to the fact that these receptors are also

GPCR Activation and Signaling Tail engagement of arrestin at the glucagon receptor Gα protein signaling bias at 5-HT1A receptor GPCRs in Cardiology, Endocrinology, and Taste Gβγ-SNAP25 exocytotic brake removal adipocyte browning, and protects against diet-induced obesity GPCRs in Neuroscience The neuropeptide receptor

A unique melanocortin-4-receptor signaling profile for obesity-associated constitutively active variants GPCRs in Neuroscience Orphan receptor GPR88 as a potential therapeutic target for CNS disorders - an Stimulation of ectopically expressed muscarinic receptors induces IFN-γ but suppresses IL-2 production